לוסרדקס 100 - Losardex 100

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

××× ×× ×× × ××¡×¤××

×§×××¦× ×¤×¨××§××××××ª (ATC4)

C09CA
Angiotensin II antagonists, plain

××¨××× ×¤×¢×× (ATC5)

Losartan potassium 100MG âC09CA01

×¦××¨×ª ××ª×

×¤××× - PER OS

×¦××¨×ª ××× ××

×§×¤××××ª, CAPLETS
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

Hypertension: Losardex 100 is indicated for the treatment of hypertensionHeart failure: Losardex 100 is indicated for the treatment of heart failure, usually in addition to diuretics and/or digitalis, if use of an ACE inhibitor is not appropriate.Switching patients with heart failure who are stable on an ACE inhibitor to Losardex 100 is not recommended.Renal protection in Type-2 diabetic patients with proteinuria: Losardex 100 is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.Reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. Losardex 100 is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.The benefit of Losardex 100 on the primary deposite endpoint was largely driven by reduction in the risk of stroke.

× ×ª×× × ××¡×

×ª××¨×× ××××× ××¡×

01/03/2002

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

××ª××××	×ª××¨×× ×××××	×ª××× ×§××× ×	Class Effect	××¦× ××××	××¡××¡ ××××××ª
×××¤×× ×××××× ××©×ª× ××ª××ª ×-1 ××¨× ×××¢× ×-30 ×"×, ×¢×××¨ ×××× ×©×× ×¡××× ×××ª×¨ ×××¥ ×× ×× ×× ×¡×¤××§×ª ××, ××¡××× ×× ××¡×£ ××¨×××©××ª ××××¤×× ××ª××©××¨×× ××©××××× ×××©×¤××ª ××¢××× ACE ×× ×©×¤××ª× ×ª××¤×¢××ª ××××× ××××¤×× ×××××¨.			OLMESARTAN MEDOXOMIL VALSARTAN LOSARTAN IRBESARTAN CANDESARTAN
×××× ××¡××× ××¤×¨××××× ××¨×× ××¢× 1 ××¨×, ××©×××× ×¢× ××¢××× ACE
×××× ××¡××× ×××ª×¨ ×××¥ ×× ×× ×× ×¡×¤××§×ª ×× ××¡××× ×× ××¡×£ ××¨×××©××ª ××××¤×× ××ª××©××¨×× ××©××××× ×××©×¤××ª ××¢××× ACE ×× ×©×¤××ª× ×ª××¤×¢××ª ××××× ××××¤××

×©××××© ××¡×

××¡××¨×ª ××××× ××¡×

××ª×¨××¤× ×××××¨× ×ª×× ×ª× ×××§×¨×× ××××:

×. ×××× ××¡××× ×××ª×¨ ×××¥ ×× ×× ×× ×¡×¤××§×ª ×× ××¡××× ×× ××¡×£ ××¨×××©××ª ××××¤×× ××ª××©××¨×× ××©××××× ×××©×¤××ª ××¢××× ACE ×× ×©×¤××ª× ×ª××¤×¢××ª ××××× ××××¤×× ×××××¨;

×. ×××¤×× ×××××× ××©×ª× ××ª××ª ×-1 ××¨× ×××¢× ×-30 ×"×, ×¢×××¨ ×××× ×©×× ×¡××× ×××ª×¨ ×××¥ ×× ×× ×× ×¡×¤××§×ª ××, ××¡××× ×× ××¡×£ ××¨×××©××ª ××××¤×× ××ª××©××¨×× ××©××××× ×××©×¤××ª ××¢××× ACE ×× ×©×¤××ª× ×ª××¤×¢××ª ××××× ××××¤×× ×××××¨.

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

××× ×¢××× ××¨××¤×
Â

××××¨× ××¢××× 22.01.2020
××××¨× ××¢××× 22.01.2020
××××¨× ××¢××× ××¦×¨×× 26.12.2016
××××¨× ××¢××× ××¦×¨×× 11.11.2014 (××¡×× Microsoft Word)
××××¨× ××¢××× ××¦×¨×× 14.04.2013 (××¡×× Microsoft Word)

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 22.01.2020 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 22.01.2020 ×¢××× ××¦×¨×× ×× ××××ª - Patient information leafletâ 22.01.2020

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×××¡×¨××§×¡ 100 ×××××¨ ××©×¨× ×××¨××××ª ×××¡×¨××§×¡ 100 ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	DEXCEL LTD, ISRAEL
×©× ××¢× ××¨××©××	DEXCEL PHARMA TECHNOLOGIES LTD
×¨××©×××	×ª××¨×× ×××©×: 11/2011. ×¨××©××× ××ª××¨××: 03/2013
×ª××¨×× ×¢×××× ×××¨××	14/05/19

השינוי האחרון נעשה בֹ־17 במרץ 2014 ב־07:07

לוסרדקס 100 - Losardex 100

ויקיתרופות